Direkt zum Inhalt
Merck
  • Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries.

Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries.

Circulation (2014-02-28)
Peter Ong, Anastasios Athanasiadis, Gabor Borgulya, Ismail Vokshi, Rachel Bastiaenen, Sebastian Kubik, Stephan Hill, Tim Schäufele, Heiko Mahrholdt, Juan Carlos Kaski, Udo Sechtem
ZUSAMMENFASSUNG

Coronary spasm can cause myocardial ischemia and angina in patients with and those without obstructive coronary artery disease. However, provocation tests using intracoronary acetylcholine administration are rarely performed in clinical routine in the United States and Europe. Thus, we assessed the clinical usefulness, angiographic characteristics, and safety of intracoronary acetylcholine provocation testing in white patients with unobstructed coronary arteries. From September 2007 to June 2010, a total of 921 consecutive patients (362 men, mean age 62±12years) who underwent diagnostic angiography for suspected myocardial ischemia and were found to have unobstructed coronary arteries (no stenosis ≥50%) were enrolled. The intracoronary acetylcholine provocation testing was performed directly after angiography according to a standardized protocol. Three hundred forty-six patients (35%) reported chest pain at rest, 222 (22%) reported chest pain on exertion, 238 (24%) reported a combination of effort and resting chest pain, and 41 (4%) presented with troponin-positive acute coronary syndrome. The overall frequency of epicardial spasm (>75% diameter reduction with angina and ischemic ECG shifts) was 33.4%, and the overall frequency of microvascular spasm (angina and ischemic ECG shifts without epicardial spasm) was 24.2%. Epicardial spasm was most often diffuse and located in the distal coronary segments (P<0.01). No fatal or irreversible nonfatal complications occurred. However, 9 patients (1%) had minor complications (nonsustained ventricular tachycardia [n=1], fast paroxysmal atrial fibrillation [n=1], symptomatic bradycardia [n=6], and catheter-induced spasm [n=1]). Epicardial and microvascular spasm are frequently found in white patients with unobstructed coronary arteries. Epicardial spasm is most often diffuse and located in the distal coronary segments. The intracoronary acetylcholine provocation test is a safe technique to assess coronary vasomotor function.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Acetylcholinchlorid, ≥99% (TLC)
Sigma-Aldrich
Acetylcholinchlorid, suitable for cell culture
Sigma-Aldrich
Acetylcholinchlorid, pkg of 150 mg (per vial)
USP
Acetylcholinchlorid, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Acetylcholinbromid, ≥99%
Sigma-Aldrich
Acetylcholiniodid, ≥97%
Acetylcholinchlorid, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Acetylcholinchlorid, ≥99% (TLC), free-flowing, Redi-Dri